Chief Scientific Officer · Tenaya Therapeutics, Inc. (TNYA)

Timothy Hoey

A named executive officer of Tenaya Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$2,561,519

Salary $420,459Stock awards $0

FY2021: $619,307

2nd of 4 named executive officers at Tenaya Therapeutics by FY2022 total.

4 named officers on file for Tenaya Therapeutics, FY2022

Timothy Hoey’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tenaya Therapeutics’s whole pay program stands against its peers

  • Tenaya Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TNYA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Timothy Hoey’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Timothy Hoey compensation by year

Tenaya Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Tenaya Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022
Salary$387,083$420,459
Bonus$0$0
Stock awards$0$0
Option awards$93,996$1,988,515
Non-equity incentive$134,000$147,000
Pension and deferred compensation$0$0
All other$4,227$5,544
Total$619,307$2,561,519

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tenaya Therapeutics, Inc. DEF 14A filed April 27, 2023, accession 0001193125-23-122205, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Tenaya Therapeutics, Inc. filed document, accession 0001193125-23-122205. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2023.

$619K
$2.6M
FY21
FY22
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
Option2,709—$2.70
Option8,681—$5.64
Option133,000—$15.19

Per the Outstanding Equity Awards at Fiscal Year-End table in Tenaya Therapeutics, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

6 Form 4 lines since the FY2022 proxy (filed April 27, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-03-05Sale10b5-13,300$7.00245,346
2024-02-23Grant or award—12,500$0.00248,646
2024-02-23Grant or award derivative—75,000$0.0075,000
2024-02-20Sale10b5-16,369$5.31236,346
2024-02-20Sale10b5-1200$6.17236,146
2024-02-16Sale—4,681$5.86242,715

The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Tenaya Therapeutics’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Faraz AliChief Executive Officer$5,567,400
Timothy Hoey · this pageChief Scientific Officer$2,561,519
Whittemore TingleyChief Medical Officer$2,290,907
Leone PattersonChief Financial and Business Officer$1,365,241

The full Tenaya Therapeutics compensation record

free company brief

This page is one person within Tenaya Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tenaya Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Timothy Hoey's compensation dossier · One-time report. No refunds.